Sun Biomedical (ASX:SBN) Payments to Suppliers for Goods and Services : A$-19.19 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Sun Biomedical Payments to Suppliers for Goods and Services?

Sun Biomedical's Payments to Suppliers for Goods and Services for the six months ended in Dec. 2023 was A$-10.35 Mil.

Sun Biomedical's Payments to Suppliers for Goods and Services for the trailing twelve months (TTM) ended in Dec. 2023 was A$-19.19 Mil.

Sun Biomedical Payments to Suppliers for Goods and Services Historical Data

The historical data trend for Sun Biomedical's Payments to Suppliers for Goods and Services can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Biomedical Payments to Suppliers for Goods and Services Chart

Sun Biomedical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Payments to Suppliers for Goods and Services

Get a 7-Day Free Trial

-3.84

-5.99

-9.62

-17.61

-18.85

Sun Biomedical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Payments to Suppliers for Goods and Services	Get a 7-Day Free Trial															-6.91	-10.70	-10.02	-8.83	-10.35

Sun Biomedical Payments to Suppliers for Goods and Services Calculation

A company's cash flow from operations for a time period can be determined using either the direct or indirect method. The indirect method modifies the operating section from accrual accounting to a cash basis by taking the net income generated in a period and adding or subtracting changes in the asset and liability accounts to determine the implied cash flow. However, the direct method uses actual cash inflows and outflows from the company's operations directly. Payments to Suppliers for Goods and Services represents cash paid to suppliers when purchasing goods or services by the company in the direct cash flow method.

Payments to Suppliers for Goods and Services for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-19.19 Mil.

Sun Biomedical (ASX:SBN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sun Biomedical Ltd (ASX:SBN) » Definitions » Payments to Suppliers for Goods and Services

Comparable Companies

Traded in Other Exchanges

DXB:Australia

Address

425 Smith Street, Fitzroy, VIC, AUS, 3065

Website

https://www.dimerix.com

Dimerix Ltd is a biopharmaceutical company developing innovative new therapies in areas with unmet medical needs. The company is developing five product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for COVID-19 pneumonia patients in ICU; DMX-200 for respiratory complications in Covid-19 patients; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.

Sun Biomedical (ASX:SBN) Headlines

No Headlines